GIA
VNDA icon

GHP Investment Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

GHP Investment Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Hold
4
– – ﹤0.01% 1381
2026
Q1 		$28 Buy
+4
New +$31 ﹤0.01% 1414

Other funds holding VNDA

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

GHP Investment Advisors's VNDA Position: Q2 2026 in Review

GHP Investment Advisors held its Vanda Pharmaceuticals (VNDA) position steady in Q2 2026 at 4 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

GHP Investment Advisors first reported a position in VNDA in Q1 2026 and has held it in 2 quarters since. The position peaked at $28 in Q1 2026. 32 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • GHP Investment Advisors held 4 shares of Vanda Pharmaceuticals worth $25 as of Q2 2026.
  • GHP Investment Advisors left its Vanda Pharmaceuticals share count unchanged in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1381 holding.
  • GHP Investment Advisors first reported a position in Vanda Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • GHP Investment Advisors's Vanda Pharmaceuticals position peaked at $28 in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.